Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.

Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, ...

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on the ...

These pro-inflammatory cytokines not only drive the autoimmune process but also create an environment conducive to chronic inflammation. Conversely, in the context of cancer, the cytokine milieu ...

Patients with atopic dermatitis were at greater risk for serious infection after initiating Janus kinase inhibitors vs Th2 cytokine inhibitors.

You will be redirected to our submission process. The field of cytokine profiling in various diseases, including Theleria annulata infection, neuroinflammatory disorders, dengue hemorrhagic fever, ...

Objective Interleukin (IL)-40 is a new cytokine related to immune system function and malignancies. Recently, an association of IL-40 with rheumatoid arthritis (RA) and externalisation of neutrophil ...

Background and aims—Cytokine production by endothelial cells has, for practical reasons, been chiefly studied in human umbilical vein endothelial cells (HUVEC) but, because tissue-specific differences ...

Also called the ‘cytokine storm’, hypercytokinemia is a condition where too many cytokines are released. “They over-trigger the immune system. It’s like a war — if the opposite side has ...